GlassScriptPhysician profile
Ossama E Sakr
NPI 1689623431
$1,234.72
in general payments reported to CMS, 2019-2025
21 companies · $270 in 2025
The $270 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2021: $23.93 · 2022: $225 · 2023: $362 · 2024: $216 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $824 · Travel and Lodging: $24.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $824.11 |
| Travel and Lodging | $24.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $272.83 | 2022-2025 | Botox |
| Heartflow, INC. | $134.66 | 2025 | |
| Angiodynamics, INC. | $107.26 | 2023 | Nanoknife |
| Astellas Pharma US INC | $99.95 | 2019 | |
| Janssen Biotech, INC. | $96.25 | 2022-2024 | Erleada |
| Karl Storz Endoscopy-America | $80.02 | 2023 | |
| Endo USA, INC. | $58.31 | 2025 | Xiaflex |
| Progenics Pharmaceuticals, INC. | $50.88 | 2022 | |
| Endo Pharmaceuticals INC. | $44.71 | 2022 | |
| Pfizer INC. | $30.23 | 2019-2024 | |
| Palette Life Sciences, INC. | $29.62 | 2023 | |
| Antares Pharma, INC. | $28.67 | 2024 | Xyosted |
| Urogen Pharma, INC. | $26.33 | 2025 | |
| Immunitybio, INC. | $24.34 | 2024 | |
| Blue Earth Diagnostics | $23.93 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $23.93 | 2021 | |
| Procept Biorobotics Corporation | $23.53 | 2025 | |
| Metuchen Pharmaceuticals | $22.86 | 2019 | |
| Novartis Pharmaceuticals Corporation | $21.85 | 2024 | |
| Ferring Pharmaceuticals INC. | $18.68 | 2024 | Adstiladrin |
| Boston Scientific Corporation | $15.88 | 2023 | Spaceoar Vue System - 10ml |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ossama Sakr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.